Skip to main content
. 2014 May 30;4(5):e214. doi: 10.1038/bcj.2014.34

Figure 3.

Figure 3

Anthracycline-containing regimens are associated with improved survival in the absence of stem cell transplantation. Overall survival for all patients (a) and PTCL-NOS/AITL patients (b) stratified by anthracycline use and stem cell transplantation status.